# US 2023/0147287 A1 · Genome engineering method and genome engineering kit

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0147287 A1
- Document ID: US20230147287A1
- Status: Published application
- Kind: A1
- Application number: 17/917,188
- Filed: 2021-04-05
- Published: 2023-05-11
- Earliest claimed: 2020-04-06
- Assignees: Logomix, Inc.; Tokyo Institute of Technology
- Applicants: Logomix, Inc.; Tokyo Institute of Technology
- Inventors: Yasunori AIZAWA; Tomoyuki OHNO
- Web page: https://patentgrep.com/patent/US20230147287A1

## CPC

- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 15/907: {in mammalian cells}
- C12N 5/0693: {Tumour cells; Cancer cells}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/1135: {against oncogenes or tumor suppressor genes}
- C12N 15/1137: {against enzymes (viral enzymes C12N15/1131; receptors C12N15/1138)}
- C12N 15/1138: {against receptors or cell surface proteins}
- C12Y 201/01107: Uroporphyrinogen-III C-methyltransferase (2.1.1.107)
- C12N 15/85: for animal cells
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Provided are a genome engineering method and a genome engineering kit which can efficiently engineer two or more alleles and are capable of engineering a relatively large region. The present invention provides a genome engineering method for engineering two or more alleles, comprising the steps of: (a) introducing the following (i) and (ii) to a cell comprising the chromosome: (i) a genome engineering system comprising a sequence-specific nucleic acid cleaving molecule targeting a target region in the chromosomal genome, or a polynucleotide encoding the sequence-specific nucleic acid cleaving molecule, and (ii) two or more donor DNAs for selective markers respectively having different selective marker genes (the number of types of the donor DNAs for selective markers are equal to or more than the number of the alleles that are subject to genome engineering); and (b) selecting the cell on the basis of all the selective marker genes carried by the two or more donor DNAs for selective markers.

## Claims

### Claim 1

A method for preparing a cell in which two or more alleles in a chromosomal genome are engineered, comprising the steps of:
(a) introducing the following (i) and (ii) to a cell comprising two or more alleles to introduce a selective marker gene to each of the two or more alleles:
(i) a genome engineering system comprising a sequence-specific nucleic acid cleaving molecule capable of targeting a target region in the two or more alleles in the chromosomal genome and cleaving the target region, or a polynucleotide encoding the sequence-specific nucleic acid cleaving molecule, and
(ii) two or more donor DNAs for selective markers, each of which has an upstream homology arm having a nucleotide sequence that can be homologously recombined with an upstream nucleotide sequence of the target region and a downstream homology arm having a nucleotide sequence that can be homologously recombined with a downstream nucleotide sequence of the target region, and comprises a nucleotide sequence of the selective marker gene between the upstream homology arm and the downstream homology arm, the two or more donor DNAs for selective markers respectively having distinguishably different selective marker genes, wherein the selective marker gene is unique to each type of donor DNA for the selective marker, and the number of types of the donor DNAs for selective markers is equal to or more than the number of the alleles that are subject to genome engineering; and
(b) after the step (a), selecting a cell having the distinguishably different unique selective marker genes, which are respectively introduced in the two or more alleles by respective homologous recombination of the two or more alleles with different types of donor DNAs for selective markers, and expressing all the distinguishably different selective marker genes thus introduced.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The method according to claim 1, wherein the target region has a length of 5 kbp or more.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the target region has a length of 8 kbp or more.

### Claim 5 (depends on 1)

The method according to claim 1, wherein each of the two or more donor DNAs for selective markers has a selective marker gene for positive selection, a marker gene for negative selection, and a target sequence between the upstream homology arm and the downstream homology arm, wherein in the case of using the selective marker gene both for positive selection and for negative selection, another selective marker gene for negative selection is optionally absent,
the method further comprising the steps of:
(c) after the step (b), introducing the following (iii) and (iv) to the selected cell to introduce a donor DNA for recombination to each of the two or more alleles:
(iii) a genome engineering system comprising a sequence-specific nucleic acid cleaving molecule capable of targeting the target sequence and cleaving the target sequence, or a polynucleotide encoding the sequence-specific nucleic acid cleaving molecule, and
(iv) a donor DNA for recombination comprising a desired nucleotide sequence, the donor DNA for recombination having an upstream homology arm having a nucleotide sequence that can be homologously recombined with an upstream nucleotide sequence of the target region and a downstream homology arm having a nucleotide sequence that can be homologously recombined with a downstream nucleotide sequence of the target region; and
(d) after the step (c), selecting a cell not expressing the marker gene for negative selection (step for negative selection).

### Claim 6 (depends on 3)

The method according to claim 3, wherein
each of the two or more donor DNAs for selective markers has a selective marker gene for positive selection, a marker gene for negative selection, and a target sequence between the upstream homology arm and the downstream homology arm, wherein in the case of using the selective marker gene both for positive selection and for negative selection, another selective marker gene for negative selection is optionally absent,
the method further comprising the steps of:
(c) after the step (b), introducing the following (iii) and (iv) to the selected cell to introduce a donor DNA for recombination to each of the two or more alleles:
(iii) a genome engineering system comprising a sequence-specific nucleic acid cleaving molecule capable of targeting the target sequence and cleaving the target sequence, or a polynucleotide encoding the sequence-specific nucleic acid cleaving molecule, and
(iv) a donor DNA for recombination comprising a desired nucleotide sequence, the donor DNA for recombination having an upstream homology arm having a nucleotide sequence that can be homologously recombined with an upstream nucleotide sequence of the target region and a downstream homology arm having a nucleotide sequence that can be homologously recombined with a downstream nucleotide sequence of the target region; and
(d) after the step (c), selecting a cell not expressing the marker gene for negative selection (step for negative selection).

### Claim 7 (depends on 4)

The method according to claim 4, wherein
each of the two or more donor DNAs for selective markers has a selective marker gene for positive selection, a marker gene for negative selection, and a target sequence between the upstream homology arm and the downstream homology arm, wherein in the case of using the selective marker gene both for positive selection and for negative selection, another selective marker gene for negative selection is optionally absent,
the method further comprising the steps of:
(c) after the step (b), introducing the following (iii) and (iv) to the selected cell to introduce a donor DNA for recombination to each of the two or more alleles:
(iii) a genome engineering system comprising a sequence-specific nucleic acid cleaving molecule capable of targeting the target sequence and cleaving the target sequence, or a polynucleotide encoding the sequence-specific nucleic acid cleaving molecule, and
(iv) a donor DNA for recombination comprising a desired nucleotide sequence, the donor DNA for recombination having an upstream homology arm having a nucleotide sequence that can be homologously recombined with an upstream nucleotide sequence of the target region and a downstream homology arm having a nucleotide sequence that can be homologously recombined with a downstream nucleotide sequence of the target region; and
(d) after the step (c), selecting a cell not expressing the marker gene for negative selection (step for negative selection).

### Claim 8 (depends on 5)

The method according to claim 5, wherein the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination has a length of 5 kbp or more.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination has a length of 5 kbp or more.

### Claim 10 (depends on 7)

The method according to claim 7, wherein the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination has a length of 5 kbp or more.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination has a length of 8 kbp or more.

### Claim at position 12

12-19. (canceled)

### Claim 20 (depends on 5)

The method according to claim 5, wherein the donor DNA for recombination has no nucleotide sequence in the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination, and the upstream and downstream sequences of the target region are seamlessly linked, without insertion, substitution and deletion of a base, in the thus-engineered two or more alleles in the chromosomal genome.

### Claim 21 (depends on 6)

The method according to claim 6, wherein the donor DNA for recombination has no nucleotide sequence in the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination, and the upstream and downstream sequences of the target region are seamlessly linked, without insertion, substitution and deletion of a base, in the thus-engineered two or more alleles in the chromosomal genome.

### Claim 22 (depends on 3)

The method according to claim 3, wherein a target sequence of site-specific recombinase is absent in the thus-engineered two or more alleles in the chromosomal genome.

### Claim 23 (depends on 4)

The method according to claim 4, wherein a target sequence of site-specific recombinase is absent in the thus-engineered two or more alleles in the chromosomal genome.

### Claim 24 (depends on 5)

The method according to claim 5, wherein a target sequence of site-specific recombinase is absent in the thus-engineered two or more alleles in the chromosomal genome.

### Claim 25 (depends on 6)

The method according to claim 6, wherein a target sequence of site-specific recombinase is absent in the thus-engineered two or more alleles in the chromosomal genome.

### Claim 26 (depends on 1)

The method according to claim 1, wherein in the step (b), single-cell cloning is not performed in a process up to the selection of the cell in which the two or more alleles are engineered.

### Claim 27

A cell having two or more alleles in the chromosomal genome in relation to a target region, wherein the respective target regions of the two or more alleles are deleted, and the upstream and downstream sequences of the target region are seamlessly linked without insertion, substitution and deletion of a base.

### Claim 28 (depends on 27)

The cell according to claim 27, wherein the target region has a length of 5 kbp or more.

### Claim 29 (depends on 27)

The cell according to claim 27, wherein the cell has no target sequence of site-specific recombinase in the genome.

### Claim 30 (depends on 6)

The method according to claim 6, wherein the region between the upstream homology arm and the downstream homology arm of the donor DNA for recombination has a length of 8 kbp or more.

### Claim 31

(canceled)
